Other Research Opportunities in Pulmonary Hypertension

The more scientists know about pulmonary hypertension, the more opportunities there are to study PH in both clinical and laboratory settings. Below are some of the opportunities currently available.

National, Heart, Lung and Blood Institute (NHLBI) Research Grants

The NHLBI offers research support and training programs to non-independent and newly independent investigators. Read More

Foundation Research Grants

Robert Wood Johnson Foundation Clinical Scholars ProgramPhysicians in the Robert Wood Johnson Clinical Scholars program are offered two years of graduate-level study and research, as part of a university-based, post-residency training program. Read More

Actelion Sponsored Grants

Entelligence Young Investigators Program This program provides opportunities for young investigators to promote quality medical care and enhance patients' lives by supporting research.2013 Awardees | Learn more from Actelion

Endothelin AwardsThe Actelion Endothelin Research Awards program provides promising young investigators grants up to 100,000 Swiss Francs (CHF) towards mentored research projects for a maximum period of 12 months. Read more from Actelion

Gilead Sponsored Grants

Investigator Sponsored ResearchThrough this program, Gilead supports investigator-sponsored research conducted by third parties on Gilead's marketed products or within therapeutic areas of interest to the company. Read more from Gilead

Gilead Sciences Research Scholars ProgramThe program provides financial support to 3 junior faculty researchers for a 2-year period with the goal of enhancing understanding of PAH. Each award is funded up to $130,000. 2011 application period closed. Check back for 2012 application opportunities. Read more from Gilead

Pfizer Sponsored Grants

ASPIRE Young Investigator Awards

The mission of the 2010 ASPIRE Young Investigator Awards in Pulmonary Vascular Disease Research is to advance the medical knowledge of fundamental mechanisms of disease, mechanisms of action of current and potential future treatments, and to improve the care of patients. Read more from Pfizer

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.